Publication:

Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer's disease

Date

2021
Journal article
https://doi.org/10.1186/s13195-020-00741-z
Simple item page Full metadata Statistics
 
dc.contributor.authorWhiley, Luke
dc.contributor.authorChappell, Katie E.
dc.contributor.authorD'Hondt, Ellie
dc.contributor.authorLewis, Matthew R.
dc.contributor.authorJimenez, Beatriz
dc.contributor.authorSnowden, Stuart G.
dc.contributor.authorSoininen, Hilkka
dc.contributor.authorKloszewska, Iwona
dc.contributor.authorMecocci, Patrizia
dc.contributor.authorTsolaki, Magda
dc.contributor.authorVellas, Bruno
dc.contributor.authorSwann, Jonathan R.
dc.contributor.authorHye, Abdul
dc.contributor.authorLovestone, Simon
dc.contributor.authorLegido-Quigley, Cristina
dc.contributor.authorHolmes, Elaine
dc.contributor.imecauthorD'Hondt, Ellie
dc.contributor.orcidextWhiley, Luke::0000-0002-9088-4799
dc.contributor.orcidextLewis, Matthew R.::0000-0001-5760-5359
dc.contributor.orcidextSwann, Jonathan R.::0000-0002-6485-4529
dc.contributor.orcidextHye, Abdul::0000-0003-2237-4823
dc.contributor.orcidextLegido-Quigley, Cristina::0000-0002-4018-214X
dc.contributor.orcidimecD'Hondt, Ellie::0000-0002-1451-4569
dc.date.accessioned2022-02-23T15:33:33Z
dc.date.available2022-02-23T15:33:33Z
dc.date.issued2021
dc.identifier.doi10.1186/s13195-020-00741-z
dc.identifier.issn1758-9193
dc.identifier.pmidMEDLINE:33422142
dc.identifier.urihttps://imec-publications.be/handle/20.500.12860/39062
dc.publisherBMC
dc.source.issue1
dc.source.journalALZHEIMERS RESEARCH & THERAPY
dc.source.numberofpages18
dc.source.volume13
dc.subject.keywordsQUINOLINIC ACID
dc.subject.keywordsPLASMA BIOMARKERS
dc.subject.keywordsTRANSGENIC MICE
dc.subject.keywordsGUT MICROBIOTA
dc.subject.keywordsINFLAMMATION
dc.subject.keywordsPERFORMANCE
dc.subject.keywordsDISCOVERY
dc.subject.keywordsDEMENTIA
dc.subject.keywordsSYSTEM
dc.title

Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer's disease

dc.typeJournal article
dspace.entity.typePublication
Files

Original bundle

Name:
s13195-020-00741-z.pdf
Size:
3.35 MB
Format:
Adobe Portable Document Format
Description:
Published version
Download
Publication available in collections:
Articles